Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear Members, The abstract submission deadline for CBS 2023 in Halifax has been extended to March 17th, 2023 Please click here to learn more...

The Exploration of Biomat-X EBMX invites you to submit your next original contribution to the inaugural edition of this journal to help the journal positioning itself among the major players in the field...

Dear Members, Reistration for CBS 2023 at Dalhousie University in Halifax, NS is officially open You can register here...

Dear CBS Members, There is only one week left to submit late breaking abstracts for the annual TERMIS-AM conference this April in Boston You can submit your abstracts here...

When treating cataracts, opacified lenses are replaced by surgically inserted artificial intraocular lenses IOLs ...

There is a significant need to evaluate the efficacy and safety of the potential drug candidates in early-stage of the development pipeline to prevent skyrocketing costs of failure in the late-stages of clinical trials or drugs attrition from the market 1...

Cell therapy is increasingly used to treat various diseases such myocardial infarction. This therapeutic approach is limited however by the poor retention and diminished survival of transplanted cells in the ischemic, inflammatory and oxidative infarct microenvironment...

Inflammation is primarily mediated by the innate immune system, and is a necessary stage in healthy wound healing that removes wound debris, prevents infection, and prepares the wound bed for tissue formation...

The development of minimally invasive procedures and tissue engineering strategies has led to a growing need for injectable materials...